NCT02176239View on ClinicalTrials.gov

Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Primary Immunodeficiency Disease (PIDD)
Trial Locations (4)

30342

Atlanta ENT, Atlanta

66219

AxelaCare Health Solutions, LLC, Lenexa

80122

IMMUNEOe International Research Centers, Centennial

92663

Hoag Medical Group (In Alliance with St. Joseph Heritage Healthcare), Newport Beach

Sponsors
All Listed Sponsors
collaborator

Bio Products Laboratory (BPL)

UNKNOWN

lead

BriovaRx Infusion Services

INDUSTRY